• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 CATHERA; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 CATHERA; CATHETER, CONTINUOUS FLUSH Back to Search Results
Model Number FG15150-0615-1S
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Granuloma (1876); Dysphasia (2195); Confusion/ Disorientation (2553)
Event Date 04/08/2024
Event Type  Injury  
Event Description
Medtronic received information that up until around march 22, daily life (single living) was confirmed; starting from march 23, the patient had an epileptic seizure and could not operate the smartphone (according to the patient).On march 27, the message on line was not read (usually the message was read immediately). on march 28, the family member (living separately) visited the patient for a scheduled visit to the department and found the patient lying next to the bed in an incontinent state. eyes opening to call, no upper extremity paralysis, no aphasia, there is dysarthria, there is disorientation, but the patient is semi-awake 140/100. mri/mra no acute stent occlusion, there is left frontal/parietal lobe flair high/dwi negative cortical lesion, and there is left temporal lobe medial left thalamus medial flair high/dwi negative cortical lesion. mri findings strongly suggest that foreign-body granuloma is the primary cause and that symptomatic epilepsy due to it is strongly suspected, and that thromboembolism should also be investigated (although it is a sufficient condition to be suspected). increasing the diagnostic accuracy and differentiating diagnosis require contrast mri and dsa, however, it was determined that it would be desirable after improvement in renal function; transfusion-loaded steroid (rinderon 2mg) antiepileptic (levetiracetam 250mg x 2/day) antithrombotic (argatroban 40mg/day bayaspirin 100mg clopidogrel 75 mg) antibiotics (cefamezin) initiated.2024-apr-12 ared (rep, hcp, for): additional information received reported from the mri findings, foreign body granulomatosis is the main cause, and symptomatic epilepsy due to it is strongly suspected.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CATHERA
Type of Device
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key19193607
MDR Text Key341172058
Report Number2029214-2024-00769
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K151638
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/31/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberFG15150-0615-1S
Device Catalogue NumberFG15150-0615-1S
Device Lot Number227567176
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/08/2024
Initial Date FDA Received04/26/2024
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/31/2024
Date Device Manufactured10/20/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient SexFemale
-
-